Zepbound News

Zepbound’s and Ozempic’s greatest benefit may be their anti-inflammatory power - Scientific American

Zepbound’s and Ozempic’s greatest benefit may be their anti-inflammatory power Scientific American

Thanks to GLP-1s, Obesity Experts Are Trying to Understand ‘Food Noise’ - The New York Times

Thanks to GLP-1s, Obesity Experts Are Trying to Understand ‘Food Noise’ The New York Times

Endoscopic procedure can help slow weight rebound from stopping GLP-1 treatment: study - Fierce Biotech

Endoscopic procedure can help slow weight rebound from stopping GLP-1 treatment: study Fierce Biotech

Restrictions on obesity drug coverage force patients to pivot - NPR

Restrictions on obesity drug coverage force patients to pivot NPR

FDA approves Eli Lilly's GLP-1 pill, opening the next phase of the weight loss drug market - CNBC

FDA approves Eli Lilly's GLP-1 pill, opening the next phase of the weight loss drug market CNBC

A new weight-loss pill is here. Here's how Foundayo compares to Wegovy, Zepbound, and other GLP-1 rivals. - Business Insider

A new weight-loss pill is here. Here's how Foundayo compares to Wegovy, Zepbound, and other GLP-1 rivals. Business Insider

Eli Lilly Isn't Replacing Zepbound -- It's Building an Obesity Empire - The Motley Fool

Eli Lilly Isn't Replacing Zepbound -- It's Building an Obesity Empire The Motley Fool

Quit a GLP-1? Plan to start again? It's not recommended, but plenty of people do it - NPR

Quit a GLP-1? Plan to start again? It's not recommended, but plenty of people do it NPR

When Weight-Loss Drugs Don’t Work - The New York Times

When Weight-Loss Drugs Don’t Work The New York Times

Zepbound (tirzepatide), the most prescribed weight management medication in 2025, now available in multi-dose KwikPen - investor.lilly.com

Zepbound (tirzepatide), the most prescribed weight management medication in 2025, now available in multi-dose KwikPen investor.lilly.com

Mounjaro, Zepbound Lowers Risk of Cardiovascular Death by 62% - Healthline

Mounjaro, Zepbound Lowers Risk of Cardiovascular Death by 62% Healthline

GLP-1 weight-loss drugs will still be cheap with Medicare, but there's a catch - USA Today

GLP-1 weight-loss drugs will still be cheap with Medicare, but there's a catch USA Today

Zepbound KwikPen: What It Is, How to Use It, Cost, & More - Ro

Zepbound KwikPen: What It Is, How to Use It, Cost, & More Ro

US weight-loss drugmakers slash prices in fight to win customers - BBC

US weight-loss drugmakers slash prices in fight to win customers BBC

She Lost 100 Pounds on Zepbound. Then Her Insurance Cut Her Off - Business Insider

She Lost 100 Pounds on Zepbound. Then Her Insurance Cut Her Off Business Insider

Publix Pharmacy provides access to savings on GLP-1 Zepbound multi-dose KwikPen - Publix

Publix Pharmacy provides access to savings on GLP-1 Zepbound multi-dose KwikPen Publix

Full Range of FDA-Approved GLP-1s Available on Hims & Hers - Hims & Hers Newsroom

Full Range of FDA-Approved GLP-1s Available on Hims & Hers Hims & Hers Newsroom

Multi-Dose KwikPen Now Available for Zepbound Administration - Gastroenterology Advisor

Multi-Dose KwikPen Now Available for Zepbound Administration Gastroenterology Advisor

GLP-1 Coverage For People On Medicare Is Shifting—What People On Medicare And Medicaid Should Know - Forbes

GLP-1 Coverage For People On Medicare Is Shifting—What People On Medicare And Medicaid Should Know Forbes

Media Statement: Zepbound (tirzepatide) KwikPen now available at self-pay pricing at major pharmacies nationwide in addition to LillyDirect - investor.lilly.com

Media Statement: Zepbound (tirzepatide) KwikPen now available at self-pay pricing at major pharmacies nationwide in addition to LillyDirect investor.lilly.com

Eli Lilly cuts cash prices of Zepbound weight loss drug vials on direct-to-consumer site - CNBC

Eli Lilly cuts cash prices of Zepbound weight loss drug vials on direct-to-consumer site CNBC

Eli Lilly launches new form of obesity drug Zepbound with a month’s worth of doses in one pen - CNBC

Eli Lilly launches new form of obesity drug Zepbound with a month’s worth of doses in one pen CNBC

Lilly's Taltz (ixekizumab) and Zepbound (tirzepatide) used together delivered superior efficacy in first-of-its-kind Phase 3b trial for adults with psoriasis and obesity or overweight - investor.lilly.com

Lilly's Taltz (ixekizumab) and Zepbound (tirzepatide) used together delivered superior efficacy in first-of-its-kind Phase 3b trial for adults with psoriasis and obesity or overweight investor.lilly.com

Zepbound leads to greater weight loss — and muscle loss — than Wegovy: study - FirstWord Pharma

Zepbound leads to greater weight loss — and muscle loss — than Wegovy: study FirstWord Pharma

Procedure to treat type 2 diabetes helps keep off weight after patients stop GLP-1 drugs - Reuters

Procedure to treat type 2 diabetes helps keep off weight after patients stop GLP-1 drugs Reuters

Eli Lilly to offer highest-dose Zepbound vials on LillyDirect - MSN

Eli Lilly to offer highest-dose Zepbound vials on LillyDirect MSN

Human Resources — Benefits shares four updates about prescription plan - Purdue University

Human Resources — Benefits shares four updates about prescription plan Purdue University

Video: Amazon Pharmacy’s Zepbound KwikPen strategy - Drug Store News

Video: Amazon Pharmacy’s Zepbound KwikPen strategy Drug Store News

Why Some People Switch from Semaglutide to Tirzepatide - AOL.com

Why Some People Switch from Semaglutide to Tirzepatide AOL.com

New GLP-1 weight-loss drugs are coming—and they’re stronger than Wegovy and Zepbound - Scientific American

New GLP-1 weight-loss drugs are coming—and they’re stronger than Wegovy and Zepbound Scientific American

GoodRx Expands Access to Eli Lilly and Company’s New Oral GLP-1, Foundayo™, and Zepbound® KwikPen® with Self-Pay Pricing at More Than 70,000 Pharmacies Nationwide - Business Wire

GoodRx Expands Access to Eli Lilly and Company’s New Oral GLP-1, Foundayo™, and Zepbound® KwikPen® with Self-Pay Pricing at More Than 70,000 Pharmacies Nationwide Business Wire

Queer Eye's Tan France helps unthread obesity bias as part of Zepbound's (tirzepatide) 'Changing the Thread Collection' - investor.lilly.com

Queer Eye's Tan France helps unthread obesity bias as part of Zepbound's (tirzepatide) 'Changing the Thread Collection' investor.lilly.com

Lilly and U.S. government agree to expand access to obesity medicines to millions of Americans - PR Newswire

Lilly and U.S. government agree to expand access to obesity medicines to millions of Americans PR Newswire

White House strikes deals for lower prices on obesity drugs - NPR

White House strikes deals for lower prices on obesity drugs NPR

Lilly's Taltz (ixekizumab) and Zepbound (tirzepatide) used together delivered superior efficacy in first-of-its-kind Phase 3b trial for adults with active psoriatic arthritis and obesity or overweight | Eli Lilly and Company - investor.lilly.com

Lilly's Taltz (ixekizumab) and Zepbound (tirzepatide) used together delivered superior efficacy in first-of-its-kind Phase 3b trial for adults with active psoriatic arthritis and obesity or overweight | Eli Lilly and Company investor.lilly.com